Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Septerna, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216759
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $26,523 | $219 |
| Operating expenses: | ||
| Research and development | 29,535 | 19,271 |
| General and administrative | 10,288 | 6,858 |
| Total operating expenses | 39,823 | 26,129 |
| Loss from operations | (13,300) | (25,910) |
| Other income, net: | ||
| Interest income | 5,031 | 4,462 |
Item 1. Condensed Financial Statements.
FAQ
- What is Septerna, Inc.'s R&D?
- Septerna, Inc. (SEPN) reported R&D of $29.54M in Q1 2026.
- How has Septerna, Inc.'s R&D changed year-over-year?
- Septerna, Inc.'s R&D increased by 53.3% year-over-year, from $19.27M to $29.54M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Septerna, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude